Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A review of recently described genetic alterations in central nervous system tumors.

Lucas CG, Solomon DA, Perry A.

Hum Pathol. 2019 Oct 31. pii: S0046-8177(19)30191-1. doi: 10.1016/j.humpath.2019.10.009. [Epub ahead of print]

PMID:
31678207
2.

Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.

Wood MD, Halfpenny AM, Moore SR.

Diagn Pathol. 2019 Apr 9;14(1):29. doi: 10.1186/s13000-019-0802-8. Review.

3.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW.

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9. Review.

PMID:
27157931
4.

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.

Komori T.

Neurol Med Chir (Tokyo). 2017 Jul 15;57(7):301-311. doi: 10.2176/nmc.ra.2017-0010. Epub 2017 Jun 8. Review.

5.

Molecular pathology of tumors of the central nervous system.

Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P.

Ann Oncol. 2019 Aug 1;30(8):1265-1278. doi: 10.1093/annonc/mdz164.

6.

The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.

Halliday GC, Junckerstorff RC, Bentel JM, Miles A, Jones DTW, Hovestadt V, Capper D, Endersby R, Cole CH, van Hagen T, Gottardo NG.

J Clin Neurosci. 2018 Jan;47:163-167. doi: 10.1016/j.jocn.2017.09.013. Epub 2017 Oct 6.

7.
8.

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.

Cimino PJ, Zager M, McFerrin L, Wirsching HG, Bolouri H, Hentschel B, von Deimling A, Jones D, Reifenberger G, Weller M, Holland EC.

Acta Neuropathol Commun. 2017 May 22;5(1):39. doi: 10.1186/s40478-017-0443-7.

9.

Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.

Meredith DM.

Adv Anat Pathol. 2019 Feb 1. doi: 10.1097/PAP.0000000000000225. [Epub ahead of print]

PMID:
30720470
10.

Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.

Ballester LY, Huse JT, Tang G, Fuller GN.

Hum Pathol. 2017 Nov;69:15-22. doi: 10.1016/j.humpath.2017.05.005. Epub 2017 May 23.

PMID:
28549927
11.

Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.

Malzkorn B, Reifenberger G.

Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Review.

PMID:
31025086
12.

[Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].

Malzkorn B, Reifenberger G.

Pathologe. 2019 Mar;40(2):131-139. doi: 10.1007/s00292-019-0575-6. Review. German.

PMID:
30790013
13.

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.

Lee SC.

Arch Pathol Lab Med. 2018 Jul;142(7):804-814. doi: 10.5858/arpa.2017-0449-RA. Epub 2018 May 18. Review.

PMID:
29775073
14.

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.

Paul Y, Mondal B, Patil V, Somasundaram K.

Clin Epigenetics. 2017 Apr 4;9:32. doi: 10.1186/s13148-017-0331-9. eCollection 2017.

15.

Molecular Testing of Brain Tumor.

Park SH, Won J, Kim SI, Lee Y, Park CK, Kim SK, Choi SH.

J Pathol Transl Med. 2017 May;51(3):205-223. doi: 10.4132/jptm.2017.03.08. Epub 2017 May 12. Review.

16.

[Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].

Pietsch T.

Pathologe. 2019 Mar;40(2):140-147. doi: 10.1007/s00292-019-0580-9. Review. German.

PMID:
30790012
18.

New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.

Fuller CE, Jones DTW, Kieran MW.

Am Soc Clin Oncol Educ Book. 2017;37:753-763. doi: 10.14694/EDBK_175088. Review.

19.

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi JI, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D, Unterberg A, Pfister SM, Jones DTW, van den Bent M, Hegi M, French P, Baumert BG, Stupp R, Gorlia T, Weller M, Capper D, Korshunov A, Herold-Mende C, Wick W, Louis DN, von Deimling A.

Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.

PMID:
29687258
20.

Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.

Ochirjav E, Enkhbat B, Baldandorj T, Choe G.

J Pathol Transl Med. 2019 Sep;53(5):298-307. doi: 10.4132/jptm.2019.07.15. Epub 2019 Aug 2.

Supplemental Content

Support Center